Anocca AB, a TCR-T cell therapy company, has received a certificate of good manufacturing practice (GMP) compliance from the Swedish Medical Product Agency for its in-house cell therapy manufacturing facility. The manufacturing license paves the way for Anocca’s near-term path to the clinic and long-term strategy to advance franchises of precision targeted cell therapies for different cancers. Anocca has built validated asset franchises against cancer targets including KRAS, PRAME and MAGE...